FindTrial
Sign In

Analysis of the Clinical Effects of Endovascular Repair in Treating Stanford Type B Aortic Dissection in Patients with Marfan Syndrome: A Retrospective, Multicenter, Observational Clinical Study

Analysis of the Clinical Effects of Endovascular Repair in Treating Stanford Type B Aortic Dissection in Patients with Marfan Syndrome: A Retrospective, Multicenter, Observational Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095581
Enrollment
Unknown
Registered
2025-01-09
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

TBAD patients with MFS:Endovascular therapy

Sponsors

Fudan University Affiliated Zhongshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Men or women aged >= 18 years old; 2) Diagnosed as MFS according to Ghent criteria and modified Ghent criteria; 3) The CTA result clearly diagnosed TBAD and underwent endovascular repair; 4) At least one CTA follow-up within one year after surgery.

Exclusion criteria

Exclusion criteria: 1) Patients with lesions located in the ascending aorta; 2) No clear genetic diagnosis for MFS; 3) No preoperative or postoperative follow-up CTA data available; 4) TBAD patients undergoing open surgery.

Design outcomes

Primary

MeasureTime frame
freedom from reintervention;—

Secondary

MeasureTime frame
all-cause mortality;—

Countries

China

Contacts

Public ContactZhihui Dong

Fudan University Affiliated Zhongshan Hospital

dzh926@126.com+86 135 6424 9168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026